Mammography Screening - as of 2013

Area of Science:

• Public Health
• Radiology
• Oncology

Background:

• The German Mammography Screening Programme, established in 2008 for women aged 50-69, adheres to European Guidelines amidst ongoing public and professional debate.
• Controversies surround the program's benefits versus potential harms, including false positives, overdiagnosis, and radiation exposure.

Purpose of the Study:

• To evaluate the effectiveness and risks of the German Mammography Screening Programme.
• To analyze data from randomized studies and quality-assured screening programs across 18 European countries.

Main Methods:

• Mathematical synopsis of recent European screening program publications.
• Analysis of diagnostic rates from over 4.6 million screening examinations in Germany.
• Comparison of outcomes between participants and non-participants in mammography screening.

Main Results:

• Mammography screening participants experienced a mortality reduction of 43% compared to non-participants.
• False-positive diagnoses and biopsy recommendations occurred in a small percentage of women (288/1000 called back, 74/288 biopsied).
• Overdiagnosis accounted for 4 additional carcinoma diagnoses per 1000 women over 20 years, without impacting mortality.

Conclusions:

• Mammography screening offers a significant reduction in breast cancer mortality and enables less invasive treatments.
• The risk-benefit ratio strongly supports recommending mammography screening to asymptomatic women aged 50-69.
• Educating women about quality-assured early detection options is crucial for informed healthcare decisions.